UCB SA (UCBJY)

OTCMKTS · Delayed Price · Currency is USD

150.71

+4.93 (3.38%)

Mar 9, 2026, 3:59 PM EST

UCB SA Employees

UCB SA had 9,378 employees as of December 31, 2024. The number of employees increased by 295 or 3.25% compared to the previous year.

Employees

9,378

Change (1Y)

295

Growth (1Y)

3.25%

Revenue / Employee

$930,761

Profits / Employee

$187,331

Market Cap

56.58B

Employees Chart

Employees History

Date	Employees	Change	Growth
Dec 31, 2024	9,378	295	3.25%
Dec 31, 2023	9,083	380	4.37%
Dec 31, 2022	8,703	142	1.66%
Dec 31, 2021	8,561	190	2.27%
Dec 31, 2020	8,371	765	10.06%
Dec 31, 2019	Pro	Pro	Pro
Dec 31, 2018	Pro	Pro	Pro
Dec 31, 2017	Pro	Pro	Pro
Dec 31, 2016	Pro	Pro	Pro
Dec 31, 2015	Pro	Pro	Pro

Related Stocks

Company Name	Employees
Northwest Biotherapeutics	25
CytoDyn	13
Silence Therapeutics	116
Vaxart	105
Nuo Therapeutics	9
Vicapsys Life Sciences	2
Cell Source	1
ZIVO Bioscience	7

Employee Rankings

UCB SA News

5 days ago - Belgium's UCB in autoimmune drug deal with Antengene - Reuters
4 months ago - U.S. FDA approves KYGEVVI® (doxecitine and doxribtimine), the first and only treatment for adults and children living with thymidine kinase 2 deficiency (TK2d) - PRNewsWire